Literature DB >> 8089690

An "n of 1" trial of intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.

G J Hankey, A A Todd, P L Yap, C P Warlow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8089690      PMCID： PMC1073148          DOI： 10.1136/jnnp.57.9.1137

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Controlled trials in single subjects. 1. Value in clinical medicine.

Authors:  T Johannessen
Journal:  BMJ       Date:  1991-07-20

2.  High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

Authors:  P A van Doorn; A Brand; P F Strengers; J Meulstee; M Vermeulen
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J M Bamford; P A Sandercock; C P Warlow; J Slattery
Journal:  Stroke       Date:  1989-06       Impact factor: 7.914
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.